Efficacy and Safety of GSP 301 Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (SAR)
Public ClinicalTrials.gov record NCT02870205. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Randomized, Parallel-Group Seasonal Allergic Rhinitis (SAR) Study to Evaluate the Efficacy, Safety and Tolerability of GSP 301 Nasal Spray Compared With Placebo Nasal Spray and Individual Monotherapy Formulations (Olopatadine Hydrochloride Nasal Spray and Mometasone Furoate Nasal Spray) in Adult and Adolescent Subjects (12 Years of Age and Older)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Study to evaluate the efficacy, safety and tolerability of GSP 301 NS compared with placebo NS and individual monotherapy formulations for the treatment of Seasonal Allergic Rhinitis (subjects 12 years of age and older)
Study identification
- NCT ID
- NCT02870205
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,176 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2016 (Actual)
- Primary completion
- Jan 2017 (Actual)
- Completion
- Jan 2017 (Actual)
- Last update posted
- Apr 6, 2018
2016 – 2017
United States locations
- U.S. sites
- 43
- U.S. states
- 18
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site 406 | Mission Viejo | California | — | — |
| Investigational Site 414 | Orange | California | — | — |
| Investigational Site 435 | San Diego | California | — | — |
| Investigational Site 420 | Centennial | Colorado | — | — |
| Investigational Site 444 | Colorado Springs | Colorado | — | — |
| Investigational Site 428 | Aventura | Florida | — | — |
| Investigational Site 412 | Miami | Florida | — | — |
| Investigational Site 436 | Bethesda | Maryland | — | — |
| Investigational Site 432 | South Dartmouth | Massachusetts | — | — |
| Investigational Site 426 | Minneapolis | Minnesota | — | — |
| Investigational Site 403 | Plymouth | Minnesota | — | — |
| Investigational Site 443 | Columbia | Missouri | — | — |
| Investigational Site 441 | Rolla | Missouri | — | — |
| Investigational Site 440 | St Louis | Missouri | — | — |
| Investigational Site 405 | Bellevue | Nebraska | — | — |
| Investigational Site 434 | Skillman | New Jersey | — | — |
| Investigational Site 408 | Rochester | New York | — | — |
| Investigational Site 418 | Rockville Centre | New York | — | — |
| Investigational Site 402 | High Point | North Carolina | — | — |
| Investigational Site 427 | Raleigh | North Carolina | — | — |
| Investigational Site 419 | Cincinnati | Ohio | — | — |
| United States 404 | Cincinnati | Ohio | — | — |
| United States 407 | Edmond | Oklahoma | — | — |
| Investigational Site 410 | Oklahoma City | Oklahoma | — | — |
| Investigational Site 424 | Tulsa | Oklahoma | — | — |
| Investigational Site 411 | Pittsburgh | Pennsylvania | — | — |
| Investigational Site 416 | Spartanburg | South Carolina | — | — |
| Investigational Site 415 | Austin | Texas | — | — |
| Investigational Site 442 | Austin | Texas | — | — |
| Investigational Site 417 | Boerne | Texas | — | — |
| Investigational Site 421 | Dallas | Texas | — | — |
| Investigational Site 430 | Dallas | Texas | — | — |
| Investigational Site 431 | El Paso | Texas | — | — |
| Investigational Site 433 | Kerrville | Texas | — | — |
| Investigational Site 422 | New Braunfels | Texas | — | — |
| Investigational Site 401 | San Antonio | Texas | — | — |
| Investigational Site 413 | San Antonio | Texas | — | — |
| Investigational Site 425 | San Antonio | Texas | — | — |
| Investigational Site 437 | San Antonio | Texas | — | — |
| Investigational Site 400 | Waco | Texas | — | — |
| Investigational Site 409 | Waco | Texas | — | — |
| Investigational Site 423 | Draper | Utah | — | — |
| Investigational Site 439 | Greenfield | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02870205, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 6, 2018 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02870205 live on ClinicalTrials.gov.